Trials / Unknown
UnknownNCT05300243
The Predictive Role of HPV Integration in HSIL and Cervical Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HPV integration test | The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening. |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2022-04-01
- Completion
- 2022-06-01
- First posted
- 2022-03-29
- Last updated
- 2022-03-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05300243. Inclusion in this directory is not an endorsement.